共 36 条
[1]
Chugh SS(2014)Global burden of atrial fibrillation in developed and developing nations Glob Heart. 9 113-9
[2]
Roth GA(2016)2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS Europace. 18 1609-78
[3]
Gillum RF(1998)Paroxysmal supraventricular tachycardia in the general population J Am Coll Cardiol. 31 150-7
[4]
Mensah GA(2016)2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society J Am Coll Cardiol. 67 1575-623
[5]
Kirchhof P(2016)2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 Lancet. 388 1659-724
[6]
Orejarena LA(2016)2016 ESC/EAS Guidelines for the Management of Dyslipidaemias Eur Heart J. 37 2999-3058
[7]
Page RL(2015)Hyperlipidemia in early adulthood increases long-term risk of coronary heart disease Circulation. 131 451-8
[8]
Catapano AL(2013)Sympathetic cardiac hyperinnervation and atrial autonomic imbalance in diet-induced obesity promote cardiac arrhythmias Am J Physiol Heart Circ Physiol. 305 H1530-7
[9]
Navar-Boggan AM(2015)Effects of Statins on First and Recurrent Supraventricular Arrhythmias in Patients With Mild Heart Failure (from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy) Am J Cardiol. 116 1869-74
[10]
McCully BH(2012)Omega-3 in antiarrhythmic therapy: pros position High Blood Press Cardiovasc Prev. 19 201-5